D’OXYVA® (deoxyhemoglobin vasodilator) is a novel biotechnology that can be used at home and in any practice to address innumerable aspects of patient health, especially the most vulnerable cases. Underlying many disease states are the conditions of inadequate microcirculation and impaired tissue perfusion.
In several clinical studies, D’OXYVA has been demonstrating inducing significant and lasting improvements in peripheral blood flow and cellular oxygenation, enabling subsequent tissue healing to occur. In fact, D’OXYVA is currently undergoing expanded pivotal clinical trials as a treatment for chronic ulcers secondary to diabetes.
In previous studies, patients at risk of amputation from such ulcers saw substantial wound healing even after a few days and, complete resolution, following 4-8 weeks of continued daily D’OXYVA use.
D’OXYVA® delivers supersaturated CO2 + H2O Vapor™ via the skin’s sweat pores by way of a non-invasive, non-electric, non-significant risk (NSR), handheld, light-weight transdermal delivery applicator. When an increase in CO2 is sensed by the circulatory and nervous systems, a cascade of cellular signaling occurs that leads to increased peripheral blood flow via vasodilation and vasoconstriction.
Tissue oxygenation is also increased via an increase in oxygen unloading in red blood cells (Bohr effect) as well as changes in cellular pathways related to oxygen delivery. With this increase in perfusion comes an increase in macro and micronutrient delivery to the tissue.
Add these foods to increase proper blood flow.
• Onion and garlic
• Dark chocolate
• Citrus foods
• Chili powder
• Olive oil
• Nuts and seeds
These vitamins may improve circulatory health.
• Vitamin E
• Ascorbic acid
• Vitamin K
Moderate exercise helps to improve overall blood flow.
• Walking and jogging
• Light weightlifting
• Aerobics and yoga
Essential changes you can make to improve circulation.
• Stretching any time of day
• Quitting smoking
• Getting regular massages
• Resting with feet above head
• Drinking more water
Adding the D’OXYVA biotech solution to the above recommended regimen can literally transform your physical condition and mental well-being, resulting in a total enhancement of your quality of life.
D’OXYVA® can eliminate the appearance of spider veins and varicose veins and resolve associated chronic pain. It has also been found to be efficacious in addressing other common circulatory conditions, including diabetic foot ulcers and erectile dysfunction.
Athletic users of D’OXYVA have reported a significant improvement in performance as well as a decrease in the duration of recovery from injuries. Further, D’OXYVA can improve physical status and ambulation in those struggling with various musculoskeletal and neurological conditions. Users have noted enhanced mood and cognition, increased energy and appetite, and improved sleep.
D’OXYVA is appropriate for any acute or chronic state that an improvement in perfusion may benefit. Additionally, D’OXYVA can be used for any condition in which inflammation is at play, as CO2 has been observed to suppress pro-inflammatory cytokines and augment various other elements of inflammatory pathways.
An abundance of clinical evidence that reflects the efficacy of D’OXYVA® has been compiled over the past decade. D’OXYVA use has consistently been shown to increase peripheral blood perfusion by a factor of 2-3x.
In over three dozen studies conducted at various academic institutions worldwide, nearly every subject has reported experiencing chronic pain relief following 1-2 weeks of D’OXYVA use. Additionally, study participants have consistently shown a decrease in systolic and diastolic arterial pressures.
Expanded pivotal trials using D’OXYVA to deliver an already FDA-approved pharmaceutical CO2 are currently underway at eighteen of the top twenty ranked universities in the United States. These trials are aimed at gaining FDA approval for D’OXYVA use in the treatment of diabetic foot ulcers.
D’OXYVA® use is incredibly straightforward. It can be used in virtually any setting and requires no electricity or batteries. Use requires only the applicator device and less than one fluid ounce of drinking water, which is applied to the inside of the applicator’s liquid capsule. Application typically occurs at the site of the thumb, but D’OXYVA has also shown improved efficacy when delivered elsewhere on the body, near the affected area.
Each D’OXYVA application can be accomplished in five minutes, and users can expect to see substantial measurable results within thirty to sixty minutes that can last for hours afterwards. D’OXYVA is generally intended to be used 1-4 times per day, with the frequency varying depending on individual need and severity of condition.
D’OXYVA is recognized for its exceptional safety profile. Not a single adverse event has ever been reported over the past decade of research and use.